[Clinico-laboratory and seroepidemiological examinations of children immunized with live measles vaccine prepared from genetically homogeneous strain Moscow-5].
The results of the clinico-laboratory and epidemiological study of a newly developed live measles vaccine obtained from strain Moscow-5, genetically homogeneous and cloned from strain JI-16, are presented. The data indicate that the vaccine obtained from strain Moscow-5 is safe and possesses low reactogenicity and high immunological potency, thus meeting all requirements for vaccinal preparations.
D000293:Adolescent; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis*; D002648:Child; D002675:Child, Preschool; D003370:Coturnix; D004625:Embryo, Nonmammalian; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008457:Measles / Q000276:immunology* / Q000517:prevention & control; D008458:Measles Vaccine / Q000276:immunology*; D008459:Measles virus / Q000276:immunology*; D012699:Serology / Q000379:methods; D013997:Time Factors
D000914:Antibodies, Viral; D008458:Measles Vaccine
Kliniko-laboratornye i seroepidemiologicheskie issledovaniia privitykh zhivoĭ korevoĭ vaktsinoĭ iz geneticheski odnorodnogo shtamma Moskva-5.